Logo

Biofortuna AmpDRY Air-Dried Master Mix

Jul 26, 2018

Biofortuna announced today that it will launch its ampDRY master mix for PCR applications at the American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Lab Expo 2018. The firm has developed its ampDRY hot-start master mix to allow complete endpoint or real-time PCR assays to be stabilized in a dry format at ambient temperatures for at least 12 months. Biofortuna said that it also offers full in vitro diagnostic contract manufacturing services using ampDRY, and can customize the manufacturing process to match customer requirements and develop bespoke, cost-effective stabilized products. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.